Aterian, Inc. (NASDAQ:ATER) Short Interest Update

Aterian, Inc. (NASDAQ:ATER) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 148,224 shares, a decrease of 48.7% from the December 31st total of 289,004 shares. Based on an average trading volume of 168,587 shares, the short-interest ratio is presently 0.9 days. Currently, 1.8% of the company’s stock are sold short. Currently, 1.8% of the company’s stock are sold short. Based on an average trading volume of 168,587 shares, the short-interest ratio is presently 0.9 days.

Aterian Price Performance

NASDAQ:ATER traded down $0.01 on Friday, reaching $0.69. 65,219 shares of the company’s stock were exchanged, compared to its average volume of 139,505. The stock has a fifty day simple moving average of $0.76 and a 200-day simple moving average of $0.95. Aterian has a 52 week low of $0.64 and a 52 week high of $3.50. The firm has a market cap of $6.95 million, a price-to-earnings ratio of -0.43 and a beta of 0.03.

Aterian (NASDAQ:ATER) last posted its earnings results on Thursday, November 13th. The company reported ($0.28) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.63) by $0.35. Aterian had a negative net margin of 15.73% and a negative return on equity of 47.45%. The business had revenue of $19.02 million for the quarter, compared to analysts’ expectations of $19.88 million.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ATER. Goldman Sachs Group Inc. raised its holdings in shares of Aterian by 73.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after acquiring an additional 9,026 shares in the last quarter. Ground Swell Capital LLC purchased a new stake in Aterian during the second quarter valued at $58,000. XTX Topco Ltd bought a new position in Aterian during the second quarter valued at $55,000. Citadel Advisors LLC grew its stake in shares of Aterian by 222.0% in the 3rd quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after buying an additional 22,865 shares in the last quarter. Finally, Susquehanna International Group LLP increased its holdings in shares of Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after buying an additional 30,637 shares during the last quarter. 7.02% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aterian in a research note on Wednesday, January 21st. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Aterian has a consensus rating of “Reduce” and an average target price of $4.00.

About Aterian

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.